Status:
RECRUITING
Kaltenborn Versus Active Release on Temporomandibular Joint Dysfunction
Lead Sponsor:
MTI University
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Temporomandibular disorder (TMD) is a term describing musculoskeletal conditions of the face, jaw and temporal regions. TMD is frequently associated with pain and/or dysfunction such as impaired jaw f...
Detailed Description
KMT evaluates the motions on the articular surfaces and applies them to treatment according to MacConaill's classification of synovial joints to restore the reduced accessory glides and achieve painle...
Eligibility Criteria
Inclusion
- An experienced oral and maxillofacial surgeon will diagnose patients with temporomandibular joint disorders (myofascial pain, trismus and limitation of ROM) after head and neck cancer, patients.
- Patients with 20 to 60 years old.
- 6 months after ending radiotherapy.
Exclusion
- Patients with implants.
- Current metastasis.
- Continuing radiotherapy.
- Pregnant females.
- Sensitivity to phototherapy.
- Bell's palsy.
- Subjects with disk displacement, arthralgia or osteoarthritis at TMJ.
- Subjects who received analgesics or antidepressants.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 10 2026
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT07151469
Start Date
October 1 2025
End Date
February 10 2026
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of physical therapy ,Cairo University
Cairo, Egypt, 3753450